Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
Probably false news. SCMP is a biased magazine and these figures cannot be found in any official sources.